Why is Jagsonpal Pharma falling/rising?

As of 03-Jul, Jagsonpal Pharmaceuticals Ltd is currently priced at 228.75, reflecting a decrease of 0.7, or 0.31%. The stock has underperformed its sector today by 0.79% and has experienced a trend reversal, falling after four consecutive days of gains. Despite this recent decline, the stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally positive long-term trend. Over the past year, the stock has generated a remarkable return of 68.57%, significantly outperforming the broader market, which has only returned 2.20%. However, the recent drop in delivery volume by 9.93% against the 5-day average suggests a decline in investor participation, which could be contributing to the stock's current price movement. In the broader market context, the stock's short-term performance contrasts with the benchmark, as it has gained 4.98% over the past week while the Sensex has declined by 0.62%. This indicates that Jagsonpal Pharmaceuticals has been performing well relative to the market recently, despite the current dip. The company's low debt-to-equity ratio and strong operating profit growth of 42.15% annually, along with positive results over the last four quarters, support a healthy long-term outlook. These factors suggest that while the stock may be facing short-term challenges, its fundamentals remain strong, which could lead to a recovery in the future.